Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Microsoft
MSFT
|
$834M |
| 2 |
Apple
AAPL
|
$763M |
| 3 |
Amazon
AMZN
|
$604M |
| 4 |
Meta Platforms (Facebook)
META
|
$293M |
| 5 |
Johnson & Johnson
JNJ
|
$263M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$52.4M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
$32.8M |
| 3 |
LPT
Liberty Property Trust
LPT
|
$29.6M |
| 4 |
MDCO
Medicines Co
MDCO
|
$12.9M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
$12.3M |
Sector Composition
| 1 | Technology | 23.53% |
| 2 | Healthcare | 15.94% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Communication Services | 10.49% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Comcast
CMCSA
$125B
| $625M | 0.66% | 18,170,873 +3,243,800 | +22% | +$112M |
|
27
Adobe
ADBE
$151B
| $598M | 0.63% | 1,878,739 +348,100 | +23% | +$111M |
|
28
NVIDIA
NVDA
$4.25T
| $595M | 0.63% | 2,256,530 +432,100 | +24% | +$114M |
|
29
McDonald's
MCD
$224B
| $594M | 0.63% | 3,595,182 +592,500 | +20% | +$98M |
|
30
Abbott
ABT
$231B
| $560M | 0.59% | 7,097,908 +1,318,200 | +23% | +$104M |
|
31
NextEra Energy, Inc.
NEE
$148B
| $552M | 0.59% | 2,295,283 +434,000 | +23% | +$104M |
|
32
Eli Lilly
LLY
$657B
| $544M | 0.58% | 3,919,898 +681,300 | +21% | +$94.5M |
|
33
Chevron
CVX
$324B
| $536M | 0.57% | 7,393,950 +1,362,000 | +23% | +$98.7M |
|
34
Medtronic
MDT
$119B
| $528M | 0.56% | 5,856,454 +1,049,500 | +22% | +$94.6M |
|
35
Bristol-Myers Squibb
BMY
$96B
| $514M | 0.55% | 9,213,588 +1,718,900 | +23% | +$95.8M |
|
36
Costco
COST
$418B
| $506M | 0.54% | 1,775,218 +335,000 | +23% | +$95.5M |
|
37
Accenture
ACN
$162B
| $468M | 0.5% | 2,864,138 +503,400 | +21% | +$82.2M |
|
38
Amgen
AMGN
$155B
| $468M | 0.5% | 2,306,118 +415,000 | +22% | +$84.1M |
|
39
Salesforce
CRM
$245B
| $466M | 0.49% | 3,233,342 +606,300 | +23% | +$87.3M |
|
40
Philip Morris
PM
$260B
| $457M | 0.49% | 6,262,618 +1,146,200 | +22% | +$83.6M |
|
41
Oracle
ORCL
$635B
| $446M | 0.47% | 9,235,563 +1,621,400 | +21% | +$78.4M |
|
42
Thermo Fisher Scientific
TMO
$186B
| $441M | 0.47% | 1,556,360 +293,500 | +23% | +$83.2M |
|
43
AbbVie
ABBV
$372B
| $437M | 0.46% | 5,739,361 +1,077,400 | +23% | +$82.1M |
|
44
PayPal
PYPL
$67.1B
| $414M | 0.44% | 4,329,065 +804,200 | +23% | +$77M |
|
45
IBM
IBM
$227B
| $410M | 0.44% | 3,693,615 +674,500 | +22% | +$74.8M |
|
46
Nike
NKE
$114B
| $400M | 0.42% | 4,835,861 +888,400 | +23% | +$73.5M |
|
47
American Tower
AMT
$95.5B
| $389M | 0.41% | 1,786,275 +364,500 | +26% | +$79.4M |
|
48
Danaher
DHR
$147B
| $385M | 0.41% | 2,778,920 +488,000 | +21% | +$67.5M |
|
49
Linde
LIN
$224B
| $385M | 0.41% | 2,222,543 +396,700 | +22% | +$68.6M |
|
50
Gilead Sciences
GILD
$140B
| $381M | 0.4% | 5,090,823 +938,300 | +23% | +$70.1M |
|